Cargando…
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
[Image: see text] Monoacylglycerol lipase (MAGL) is the enzyme responsible for the metabolism of 2-arachidonoylglycerol in the brain and the hydrolysis of peripheral monoacylglycerols. Many studies demonstrated beneficial effects deriving from MAGL inhibition for neurodegenerative diseases, inflamma...
Autores principales: | Bononi, Giulia, Di Stefano, Miriana, Poli, Giulio, Ortore, Gabriella, Meier, Philip, Masetto, Francesca, Caligiuri, Isabella, Rizzolio, Flavio, Macchia, Marco, Chicca, Andrea, Avan, Amir, Giovannetti, Elisa, Vagaggini, Chiara, Brai, Annalaura, Dreassi, Elena, Valoti, Massimo, Minutolo, Filippo, Granchi, Carlotta, Gertsch, Jürg, Tuccinardi, Tiziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150076/ https://www.ncbi.nlm.nih.gov/pubmed/35522977 http://dx.doi.org/10.1021/acs.jmedchem.1c01806 |
Ejemplares similares
-
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
por: Poli, Giulio, et al.
Publicado: (2019) -
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
por: Jha, Vibhu, et al.
Publicado: (2020) -
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors
por: Di Stefano, Miriana, et al.
Publicado: (2022) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017) -
α/β-Hydrolase Domain (ABHD) Inhibitors
as New Potential Therapeutic Options against Lipid-Related Diseases
por: Bononi, Giulia, et al.
Publicado: (2021)